PROKR2 is associated with methamphetamine dependence in the Japanese population

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 6, 2010, Pages 1033-1036

  Kishi, Taro ^a   Kitajima, Tsuyoshi ^a   Tsunoka, Tomoko ^a   Okumura, Takenori ^a   Okochi, Tomo ^a   Kawashima, Kunihiro ^a   Inada, Toshiya ^b,c   Ujike, Hiroshi ^b,d   Yamada, Mitsuhiko ^b,e   Uchimura, Naohisa ^b,f   Sora, Ichiro ^b,g   Iyo, Masaomi ^b,h   Ozaki, Norio ^b,i   Iwata, Nakao ^a,b  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Japanese Genetics Initiative for Drug Abuse ^*  (Japan)

^c SEIWA HOSPITAL   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^f KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Circadian rhythm; Methamphetamine dependence; Methamphetamine induced psychosis; Prokineticin 2 receptor gene (PROKR2); Tagging SNPs

Indexed keywords

GROWTH FACTOR; METHAMPHETAMINE; PROKINETICIN 2 RECEPTOR PROTEIN; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; PROKR2 PROTEIN, HUMAN; RECEPTOR;

ADULT; AGE DISTRIBUTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; CHI SQUARE DISTRIBUTION; DRUG ABUSE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

ADULT; ALLELES; AMPHETAMINE-RELATED DISORDERS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE;

EID: 77955051689     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.05.018     Document Type: Article

References (34)

1. Barnard A.R., Nolan P.M. When clocks go bad: neurobehavioural consequences of disrupted circadian timing. PLoS Genet 2008, 4:e1000040.
2. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
3. Chakravarti A. Population genetics - making sense out of sequence. Nat Genet 1999, 21:56-60.
4. Cheng M.Y., Bullock C.M., Li C., Lee A.G., Bermak J.C., Belluzzi J., et al. Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature 2002, 417:405-410.
5. Davis L., Uezato A., Newell J.M., Frazier E. Major depression and comorbid substance use disorders. Curr Opin Psychiatry 2008, 21:14-18.
6. Detera-Wadleigh S.D., Badner J.A., Yoshikawa T., Sanders A.R., Goldin L.R., Turner G., et al. Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 4, 7, 9, 18, 19, 20, and 21q. Am J Med Genet 1997, 74:254-262.
7. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003, 25:115-121.
8. Fanous A.H., Neale M.C., Webb B.T., Straub R.E., O'Neill F.A., Walsh D., et al. Novel linkage to chromosome 20p using latent classes of psychotic illness in 270 Irish high-density families. Biol Psychiatry 2008, 64:121-127.
9. Gentil V. Introduction to bipolar disorder and comorbid conditions. J Clin Psychiatry 2008, 69:e1.
10. Iijima M., Nikaido T., Akiyama M., Moriya T., Shibata S. Methamphetamine-induced, suprachiasmatic nucleus-independent circadian rhythms of activity and mPer gene expression in the striatum of the mouse. Eur J Neurosci 2002, 16:921-929.
11. Kishi T., Kitajima T., Ikeda M., Yamanouchi Y., Kinoshita Y., Kawashima K., et al. Association analysis of nuclear receptor Rev-erb alpha gene (NR1D1) with mood disorders in the Japanese population. Neurosci Res 2008, 62:211-215.
12. Kishi T., Ikeda M., Kitajima T., Yamanouchi Y., Kinoshita Y., Kawashima K., et al. Association analysis of functional polymorphism in estrogen receptor alpha gene with schizophrenia and mood disorders in the Japanese population. Psychiatr Genet 2009, 19:217-218.
13. Kishi T., Ikeda M., Kitajima T., Yamanouchi Y., Kinoshita Y., Kawashima K., et al. A functional polymorphism in estrogen receptor alpha gene is associated with Japanese methamphetamine induced psychosis. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:895-898.
14. Kishi T., Kitajima T., Ikeda M., Yamanouchi Y., Kinoshita Y., Kawashima K., Okochi T., Okumura T., Tsunoka T., Ozaki N., Iwata N. CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients. Neuromolecular Med. 2009, 1(2):53-57.
15. Kishi T., Kitajima T., Tsunoka T., Ikeda M., Yamanouchi Y., Kinoshita Y., et al. Genetic association analysis of serotonin 2A receptor gene (HTR2A) with bipolar disorder and major depressive disorder in the Japanese population. Neurosci Res 2009, 64:231-234.
16. Kishi T., Kitajima T., Tsunoka T., Okumura T., Ikeda M., Okochi T., et al. Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the Japanese population. Neuromolecular Med 2009, 11:114-122.
17. Kishi T., Tsunoka T., Ikeda M., Kawashima K., Okochi T., Kitajima T., et al. Serotonin 1A receptor gene and major depressive disorder: an association study and meta-analysis. J Hum Genet 2009, 54:629-633.
18. Kishi T., Tsunoka T., Ikeda M., Kitajima T., Kawashima K., Okochi T., Okumura T., Yamanouchi Y., Kinoshita Y., Ujike H., Inada T., Yamada M., Uchimura N., Sora I., Iyo M., Ozaki N., Iwata N. Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients. Neuropharmacology 2010 Feb, 58(2):452-456.
19. Kishi T., Yoshimura R., Okochi T., Fukuo Y., Kitajima T., Okumura T., Tsunoka T., Kawashima K., Yamanouchi Y., Kinoshita Y., Umene-Nakano W., Naitoh H., Nakamura J., Ozaki N., Iwata N. Association analysis of SIGMAR1 with major depressive disorder and SSRI response. Neuropharmacology 2010 Jun, 58(2):1168-1173.
20. Laviolette S.R. Dopamine modulation of emotional processing in cortical and subcortical neural circuits: evidence for a final common pathway in schizophrenia?. Schizophr Bull 2007, 33:971-981.
21. Li J.D., Hu W.P., Boehmer L., Cheng M.Y., Lee A.G., Jilek A., et al. Attenuated circadian rhythms in mice lacking the prokineticin 2 gene. J Neurosci 2006, 26:11615-11623.
22. Mansour H.A., Wood J., Logue T., Chowdari K.V., Dayal M., Kupfer D.J., et al. Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes Brain Behav 2006, 5:150-157.
23. Masubuchi S., Honma S., Abe H., Ishizaki K., Namihira M., Ikeda M., et al. Clock genes outside the suprachiasmatic nucleus involved in manifestation of locomotor activity rhythm in rats. Eur J Neurosci 2000, 12:4206-4214.
24. Masubuchi S., Honma S., Abe H., Nakamura W., Honma K. Circadian activity rhythm in methamphetamine-treated clock mutant mice. Eur J Neurosci 2001, 14:1177-1180.
25. Mohawk J.A., Baer M.L., Menaker M. The methamphetamine-sensitive circadian oscillator does not employ canonical clock genes. Proc Natl Acad Sci U S A 2009, 106:3519-3524.
26. Munzar P., Tanda G., Justinova Z., Goldberg S.R. Histamine h3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release. Neuropsychopharmacology 2004, 29:705-717.
27. Nievergelt C.M., Kripke D.F., Barrett T.B., Burg E., Remick R.A., Sadovnick A.D., et al. Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2006, 141B:234-241.
28. Prosser H.M., Bradley A., Chesham J.E., Ebling F.J., Hastings M.H., Maywood E.S. Prokineticin receptor 2 (Prokr2) is essential for the regulation of circadian behavior by the suprachiasmatic nuclei. Proc Natl Acad Sci U S A 2007, 104:648-653.
29. Purcell S., Cherny S.S., Sham P.C. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
30. Ross J., Berrettini W., Coryell W., Gershon E.S., Badner J.A., Kelsoe J.R., et al. Genome-wide parametric linkage analyses of 644 bipolar pedigrees suggest susceptibility loci at chromosomes 16 and 20. Psychiatr Genet 2008, 18:191-198.
31. Spanagel R., Pendyala G., Abarca C., Zghoul T., Sanchis-Segura C., Magnone M.C., et al. The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat Med 2005, 11:35-42.
32. Vocci F.J., Acri J., Elkashef A. Medication development for addictive disorders: the state of the science. Am J Psychiatry 2005, 162:1432-1440.
33. Weickert C.S., Miranda-Angulo A.L., Wong J., Perlman W.R., Ward S.E., Radhakrishna V., et al. Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum Mol Genet 2008, 17:2293-2309.
34. Zhou Q.Y., Cheng M.Y. Prokineticin 2 and circadian clock output. Febs J 2005, 272:5703-5709.